Cita APA

Soria, A., Calvo, M., Casas, M., Vidales, Z., Munoz-Martinez, S., Sapena, V., . . . Vergara, M. (2022). Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.

Citación estilo Chicago

Soria, A., et al. Survival and Adverse Events of Elderly Patients Treated With Sorafenib for Hepatocellular Carcinoma. 2022.

Cita MLA

Soria, A., et al. Survival and Adverse Events of Elderly Patients Treated With Sorafenib for Hepatocellular Carcinoma. 2022.